These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21481536)

  • 1. Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumors.
    Stoyianni A; Pentheroudakis G; Pavlidis N
    Cancer Treat Rev; 2011 Aug; 37(5):358-65. PubMed ID: 21481536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine carcinoma of unknown primary site.
    Spigel DR; Hainsworth JD; Greco FA
    Semin Oncol; 2009 Feb; 36(1):52-9. PubMed ID: 19179188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases.
    van der Laan TP; Plaat BE; van der Laan BF; Halmos GB
    Head Neck; 2015 May; 37(5):707-15. PubMed ID: 24596175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters.
    Crippa S; Partelli S; Bassi C; Berardi R; Capelli P; Scarpa A; Zamboni G; Falconi M
    Surgery; 2016 Mar; 159(3):862-71. PubMed ID: 26602841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.
    Brandi G; Paragona M; Campana D; Brighi N; Bondi A; Pantaleo MA; Corbelli J; Barbera MA; Biasco G
    J Chemother; 2018 Feb; 30(1):53-58. PubMed ID: 28641483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.
    Metro G; Ricciuti B; Chiari R; Baretti M; Falcinelli L; Giannarelli D; Sidoni A; Mountzios G; Crinò L; Bellezza G; Rebonato A; Ferolla P; Toschi L
    Lung Cancer; 2016 May; 95():82-7. PubMed ID: 27040856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large cell neuroendocrine carcinoma of the larynx: definition of an entity.
    Lewis JS; Spence DC; Chiosea S; Barnes EL; Brandwein-Gensler M; El-Mofty SK
    Head Neck Pathol; 2010 Sep; 4(3):198-207. PubMed ID: 20589486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
    Sorbye H; Baudin E; Perren A
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
    Fazio N; Milione M
    Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary neuroendocrine carcinomas. A review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification.
    Huang Q; Muzitansky A; Mark EJ
    Arch Pathol Lab Med; 2002 May; 126(5):545-53. PubMed ID: 11958659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
    Puliafito I; Chillari F; Russo A; Cantale O; Sciacca D; Castorina L; Colarossi C; Franchina T; Vitale MP; Ricciardi GRR; Adamo V; Esposito F; Giuffrida D
    Front Endocrinol (Lausanne); 2023; 14():1065599. PubMed ID: 36793289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.
    Basturk O; Tang L; Hruban RH; Adsay V; Yang Z; Krasinskas AM; Vakiani E; La Rosa S; Jang KT; Frankel WL; Liu X; Zhang L; Giordano TJ; Bellizzi AM; Chen JH; Shi C; Allen P; Reidy DL; Wolfgang CL; Saka B; Rezaee N; Deshpande V; Klimstra DS
    Am J Surg Pathol; 2014 Apr; 38(4):437-47. PubMed ID: 24503751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung.
    Dresler CM; Ritter JH; Patterson GA; Ross E; Bailey MS; Wick MR
    Ann Thorac Surg; 1997 Jan; 63(1):180-5. PubMed ID: 8993262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
    Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular pathogenesis and management of bronchial carcinoids.
    Cakir M; Grossman A
    Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.
    Matsumura Y; Umemura S; Ishii G; Tsuta K; Matsumoto S; Aokage K; Hishida T; Yoshida J; Ohe Y; Suzuki H; Ochiai A; Goto K; Nagai K; Tsuchihara K
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2159-70. PubMed ID: 25989941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system].
    Pellat A; Wislez M; Svrcek M; Hammel P; Afchain P; André T
    Bull Cancer; 2016 Oct; 103(10):880-895. PubMed ID: 27507031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.